3312- D North Oak St., Ext., Valdosta, GA 31605
Phone: (229) 244-2030
Transcranial Magnetic Stimilation
Call Today to see if you are a candidate for TMS Therapy
or fill out the form below and
we will contact you.
TMS Therapy® for Depression
For decades, researchers have sought safe and effective treatments for depression. However, there is no single depression treatment which has been proven to work for everyone. Depression is often treated with antidepressant medications; however, alternative treatments for depression are available. These depression therapies have been shown to work in people who do not receive benefit from medications or cannot tolerate the side effects caused by them. One alternative therapy for the treatment of depression is transcranial magnetic stimulation. NeuroStar TMS (transcranial magnetic stimulation) Therapy was recently FDA-cleared for patients suffering from depression who have not achieved satisfactory improvement from prior antidepressant medications.
Transcranial Magnetic Stimulation (TMS)
Transcranial magnetic stimulation therapy uses short pulses of magnetic fields to stimulate nerve cells in the area of the brain thought to control mood. It is sometimes referred to as rTMS which stands for repetitive transcranial magnetic stimulation. TMS Therapy is performed in a psychiatrist's office under his or her supervision while you remain awake and alert.
NeuroStar TMS Therapy ® is an outpatient procedure. The typical treatment course consists of 5 treatments per week over a 4-6 week period for 20-30 treatments. Each depression treatment session lasts approximately 37 minutes. NeuroStar TMS Therapy is:
•Non-invasive, meaning that it does not involve surgery. It does not require any anesthesia or sedation, as the patient remains awake and alert during the treatment.
•Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.
•FDA cleared for patients who have not benefited from prior antidepressant treatment.
* NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.